The CEO of a tiny biotech working on a coronavirus vaccine tells us how a $1.6 billion grant from the US government will 'level the playing field' with Big Pharma (NVAX)

1:15pm PDT - July 7th, 2020    novavax stock - Business Insider

  • A tiny biotech called Novavax has secured the largest deal yet from the US government to support its coronavirus vaccine program. 
  • Novavax landed a $1.6 billion funding deal that will help test its vaccine candidate in large clinical trials …